026 ObamaCare created a

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
026
ObamaCare created a Medicaid time bomb

By Michael D. Tanner
December 7, 2013 | 9:15pm

The good news, if you want to call it that, is that roughly 1.6 million Americans have enrolled in ObamaCare so far.

The not-so-good news is that 1.46 million of them actually signed up for Medicaid. If that trend continues, it could bankrupt both federal and state governments.

Medicaid is already America’s third-largest government program, trailing only Social Security and Medicare, as a proportion of the federal budget. Almost 8 cents out of every dollar that the federal government spends goes to Medicaid. That’s more than $265 billion per year.

Indeed, already Social Security, Medicare and Medicaid account for 48% of federal spending. Within the next few years, those three programs will eat up more than half of federal expenditures.

And it’s going to get worse. Congress has shown no ability to reform Social Security or Medicare. With ObamaCare adding to Medicare spending, we are picking up speed on the road to insolvency.

The Congressional Budget Office projects that, in part because of ObamaCare, Medicaid spending will more than double over the next 10 years, topping $554 billion by 2023.

And that is just federal spending.

State governments pay another $160 billion for Medicaid today. For most states, Medicaid is the single-largest cost of government, crowding out education, transportation and everything else.

New York spent more than $15 billion on Medicaid last year, roughly 30% of all state expenditures. The Kaiser Foundation projects that over the next 10 years, New York taxpayers will shell out some $433 billion for the program.

But none of these projections foresaw that so many of ObamaCare’s enrollees would be Medicaid eligible.

To be sure, the health-care law’s designers saw the expansion of Medicaid as an important feature of their plan to expand coverage for the uninsured. Still, they expected most of those enrolling in ObamaCare to qualify for private (albeit subsidized) insurance.

It’s beginning to look like that was just another miscalculation, one that could have very serious consequences for the program’s costs. (bolded for emphasis)

Moreover, any projection of Medicaid’s future cost to New York taxpayers assumes that the federal government keeps its promise to pay 100% of the cost for Medicaid’s expansion over the next three years and 90% thereafter. But given the growing burden that Medicare will put on a federal budget already facing high debt levels, how likely is it that changes in the federal share of Medicaid will stay off the table?

In fact, as part if last December’s fiscal-cliff negotiations, the Obama administration briefly considered changing to a “blended” reimbursement rate, somewhere between the current and promised rates. The administration quickly backed away from the offer, but it’s likely to come back in the future. If it does, it would cost New York tens of millions of dollars.

Every bit as bad as the cost is the fact that for all this money, recipients are going to get pretty lousy health care. (bolded for emphasis)

Of course, one might say that even bad health care is better than no health care. But, unfortunately, for Medicaid, that’s not true.

The Oregon Health Insurance Exchange study, the first randomized controlled study of Medicaid outcomes, recently concluded that, while Medicaid increased medical spending increased from $3,300 to $4,400 per person, “Medicaid coverage generated no significant improvements in measured physical-health outcomes.”

Other studies show that, in some cases, Medicaid patients actually wait longer and receive worse care than the uninsured.

While Medicaid costs taxpayers a lot of money, it pays doctors very little. On average, Medicaid only reimburses doctors 72 cents out of each dollar of costs. ObamaCare does attempt to address this by temporarily increasing Medicaid reimbursements for primary-care doctors, but that increase expires at the end of next year.

Because of the low reimbursement, and the red tape that accompanies any government program, many doctors limit the number of Medicaid patients they serve, or even refuse to take Medicaid patients at all. An analysis published in Health Affairs found that only 69% of physicians accept Medicaid patients. A study published in the New England Journal of Medicine found that individuals posing as mothers of children with serious medical conditions were denied an appointment 66% of the time if they said that their child was on Medicaid (or the related CHIP), compared with 11% for private insurance — a ratio of 6 to 1.

Even when doctors do still treat Medicaid patients, they often have a harder time getting appointments and face longer wait times. One study found that among clinics that accepted both privately insured children and those enrolled in Medicaid, the average wait time for an appointment was 42 days for Medicaid compared to just 20 days for the privately insured. One study found that among clinics that accepted both privately insured children and those enrolled in Medicaid, the average wait time for an appointment was 42 days for Medicaid compared to just 20 days for the privately insured.

That’s one reason why so many Medicaid patients show up at the emergency room for treatment. They can’t find a doctor to treat them otherwise.

This not only increases the strain on already overburdened emergency room doctors, but increases the wait for those who arrive with real emergencies.

As bad as this is now, ObamaCare will make it worse by increasing the number of people on Medicaid without doing anything to increase the number of doctors treating them.

We don’t know yet whether the rush to Medicaid will continue. It may be that the troubles with the ObamaCare website might have skewed the early signups. But if ObamaCare really does lead to a massive expansion of this costly and inefficient program, that’s bad news for taxpayers, providers and patients.

Michael D. Tanner is a senior fellow at the Cato Institute.

http://nypost.com/2013/12/07/the-medicaid-time-bomb/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Minghui and ASKA Seal Major Licensing Deal for MHB018A

Updated Category News Views 10

Breaking New Ground in Thyroid Eye Disease Treatment If there's one thing that keeps the biopharma world on its toes, it's the relentless pursuit of groundbreaking treatments. And folks, let me tell you, the latest tie-up between Minghui Pharmaceutical and ASKA Pharmaceutical has struck a chord. This union with MHB018A at its core might be one of those watershed moments...

Continue Reading
Exploring the Untold Legacy of Edgar Snow's Work

Updated Category News Views 32

The legacy of Edgar Snow is a compelling tapestry of journalism, revolution, and the indomitable human spirit, woven together in the annals of China's history. Stepping off the beaten path, you'd find Eric Foster, the nephew of Snow, retracing a journey his uncle embarked on more than ninety years ago. It's not every day that an American journalist helps change the...

Continue Reading
Direct Connection Unleashes Powerful HEMI V8 Engine Programs

Updated Category News Views 75

HEMI V8 Legacy Reinvention at SEMA 2026 If you're the sort who gets their hands greasy restoring or revamping classic muscle, well, Direct Connection just made your life a whole lot easier. Stellantis' performance arm pulled the wraps off not just one, but six new HEMI V8 crate engine packages at the 2026 SEMA Show. Now, that's how you turn heads in Vegas. A New...

Continue Reading
Edible Oils: Market Growth, Trends, and Investments

Updated Category News Views 167

Riding the Edible Oil Wave The edible oils market seems to be gearing up for a steady rise. Folks, the numbers are speaking loud and clear. We're looking at the market booming from USD 277.74 billion in 2026 to a hefty USD 351.08 billion in 2031. According to MarketsandMarkets™, a compound annual growth rate (CAGR) of 4.8% is on the cards. Now, if that doesn't get the...

Continue Reading
Q-Ball Intelligence Launches Predictive Powerhouse

Updated Category News Views 104

Breaking Out in the Predictive AI Scene Q-Ball Intelligence doesn't just stroll onto the AI stage; they bulldoze in, backed by a beefy research legacy starting way back in 2007. Now, after 19 years marinating in the depths of predictive research—and putting some serious cash where their AI mouth is—they've officially launched as the new big thing in predictive...

Continue Reading
Envision's Green Ammonia Powers Game-Changing Shipping Milestone

Updated Category News Views 78

Envision's Big Bet on Green Ammonia It's a day to talk about paradigms shifting on the high seas. Envision, a heavy hitter in the green tech arena, just fueled the very first Very Large Ammonia Carrier (VLAC) with their certified green ammonia. Now, that's not just a milestone, it’s like finding a four-leaf clover in the world of maritime decarbonization—a tough nut...

Continue Reading
Geopolitical Talks Shake Oil Market, Refine Stocks' Path

Updated Category News Views 92

Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...

Continue Reading
EX.CO Lands Spot on Duns 100 Best Companies List

Updated Category News Views 31

The tech world doesn't stop for anyone, and EX.CO seems to be riding the front of this speeding train. Cracking the top 20 of the Duns 100 list, EX.CO's snagged the 18th spot in the competitive startup category, proving their mettle in the business of transforming screens into revenue juggernauts. Riding the AI Wave In a world where AI is rewriting scripts faster than any...

Continue Reading
Cordatus Capital Takes Majority Stake in Diamabrush

Updated Category News Views 123

Let's talk straight here: when a private equity firm like Cordatus Capital jumps onto your train, it ain't just because they fancy a change of scenery or want some floor-scrubbing excitement. No, sir. This is a calculated play, and there's a chess game opening up over at Diamabrush. What's the Play? Cordatus has thrown its chips behind Diamabrush, a company that's made...

Continue Reading
Orlando's Holiday Extravaganza: Theme Parks to Unique Festivities

Updated Category News Views 67

Holiday Cheer Abounds in Orlando Orlando's never a letdown when it comes to spectacle, but this holiday season, they've taken it up a notch and a half. The city's bursting with festivities, from the iconic theme parks to lively local events that offer something for everyone. Whether you're entertaining kids or looking for grown-up glitz, Orlando's got you sorted. Merry...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Renewi Plc's Public Disclosure in 2025

Updated Category News Views 253

Overview of the Public Disclosure Rule The public disclosure of interests in relevant securities is a structured process guided by various regulations including the Takeover Code. This specific disclosure informs stakeholders about share interests representing 1% or more in companies like Renewi Plc, enhancing market transparency and confidence. Key Disclosure Information...

Continue Reading
RaySearch Laboratories AB Seeks Institutional Share Placement

Updated Category News Views 117

RaySearch Laboratories AB Plans Share Placement Johan Löf, the CEO and Founder of RaySearch Laboratories AB, has announced an important step as he prepares to sell approximately 2 million class B shares of the company. This significant move represents about 6% of the total shares of RaySearch Laboratories AB. The shares are being offered to institutional and qualified...

Continue Reading
Key Stocks to Monitor: Micron, Cintas, and More Insights

Updated Category News Views 212

Key Stocks to Monitor Today As the trading day unfolds with U.S. stock futures displaying a mixed outlook, several stocks are poised to capture the attention of investors today. Let’s dive into the details surrounding these key players. Focus on Cintas Corp. Cintas Corp. (NASDAQ: CTAS) is on the radar as it prepares to announce its quarterly earnings. Analysts...

Continue Reading
Latest Disclosure of Interests by Rathbones Group and Insights

Updated Category News Views 79

Understanding the Latest Disclosure Activities In the labyrinth of investments and share holdings, timely disclosures play a crucial role in maintaining market transparency. Recent updates from Rathbones Group Plc regarding their interests in Warehouse REIT Plc illustrate this principle vividly. Key Disclosure Information According to Rule 8.3 of the Takeover Code,...

Continue Reading
Canada Nickel's 2024 ESG Report Highlights Sustainable Growth

Updated Category News Views 156

Canada Nickel's 2024 ESG Report Highlights Sustainable Growth Canada Nickel Company Inc. (TSXV: CNC) (OTCQB: CNIKF) has unveiled its 2024 Environmental, Social, and Governance (ESG) Report, emphasizing its commitment to sustainable practices and community engagement. This report showcases the continuous advancements in carbon storage technology, partnerships with...

Continue Reading